Last reviewed · How we verify
A Randomised Trial to Assess Catheter Ablation Versus Rate-Control in the Management of Persistent Atrial Fibrillation in Chronic Heart Failure (ARC-HF)
It is still uncertain what the best treatment is for patients who have both atrial fibrillation (AF) and heart failure. The aim of the study is to help identify the optimal treatment for patients with these two significant medical conditions. This will be performed by comparing two alternative strategies for AF management: catheter ablation (to restore normal rhythm) and medical therapy (to control heart rate, but not aiming ro restore normal rhythm). After random assignment, the effect of each strategy will be assessed by looking for changes in exercise capacity, symptoms, heart pump function, and quality of life during 12 months of follow-up.
Details
| Lead sponsor | Royal Brompton & Harefield NHS Foundation Trust |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 52 |
| Start date | 2009-04 |
| Completion | 2012-07 |
Conditions
- Atrial Fibrillation
- Heart Failure
Interventions
- Medication to control ventricular rate in AF
- Catheter Ablation for Persistent Atrial Fibrillation
Primary outcomes
- Peak oxygen consumption at cardiopulmonary exercise test — 12 months
Countries
United Kingdom